Bosh sahifaGRAL • NASDAQ
add
Grail Inc
101,31 $
Dastlabki sotuv:(1,82%)+1,84
103,15 $
Yopilgan:21-yan, 4:33:10 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
96,70 $
Kunlik diapazon
93,00 $ - 106,25 $
Yillik diapazon
17,50 $ - 115,76 $
Bozor kapitalizatsiyasi
3,95 mlrd USD
Oʻrtacha hajm
761,33 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 36,19 mln | 26,32% |
Joriy xarajat | 145,03 mln | -25,53% |
Sof foyda | -88,98 mln | 29,21% |
Sof foyda marjasi | -245,83 | 43,96% |
Har bir ulushga tushum | -2,46 | 29,77% |
EBITDA | -86,31 mln | 40,18% |
Amaldagi soliq stavkasi | 25,05% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 540,13 mln | -36,72% |
Jami aktivlari | 2,60 mlrd | -16,58% |
Jami passivlari | 361,07 mln | -31,91% |
Umumiy kapital | 2,24 mlrd | — |
Tarqatilgan aksiyalar | 38,98 mln | — |
Narxi/balansdagi bahosi | 1,56 | — |
Aktivlardan daromad | -11,81% | — |
Kapitaldan daromad | -13,40% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -88,98 mln | 29,21% |
Operatsiyalardan naqd pul | -63,24 mln | 39,53% |
Sarmoyadan naqd pul | 66,67 mln | 6 966,43% |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | 3,09 mln | 102,93% |
Boʻsh pul | -19,27 mln | 60,50% |
Haqida
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
Tashkil etilgan
2015
Sayt
Xodimlar soni
1 000
